Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Ivonne Haffner"'
Autor:
Andrea Alberti, Gertraud Stocker, Florian Lordick, Ulrich T. Hacker, Benjamin Kobitzsch, Ivonne Haffner, Gian Luca Baiocchi, Manuel Zamparini, Guido A. M. Tiberio, Carla Baronchelli, Arnaldo Caruso, Paolo Bossi, Alfredo Berruti
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
PurposeThe Cancer Genome Atlas Research Network identified Epstein-Barr-Virus (EBV)-positive gastric cancer as a distinct molecular subtype. The prevalence is 8-9% and the histological examination shows pronounced lymphocytic infiltration, elevated l
Externí odkaz:
https://doaj.org/article/3398c2b0129342f29dd3ebfe3d0ece34
Autor:
Karolin Ebert, Ivonne Haffner, Gwen Zwingenberger, Simone Keller, Elba Raimúndez, Robert Geffers, Ralph Wirtz, Elena Barbaria, Vanessa Hollerieth, Rouven Arnold, Axel Walch, Jan Hasenauer, Dieter Maier, Florian Lordick, Birgit Luber
Publikováno v:
BMC Cancer, Vol 22, Iss 1, Pp 1-17 (2022)
Abstract Background The standard treatment for patients with advanced HER2-positive gastric cancer is a combination of the antibody trastuzumab and platin-fluoropyrimidine chemotherapy. As some patients do not respond to trastuzumab therapy or develo
Externí odkaz:
https://doaj.org/article/d7771994bd154b28a634642df9bb9541
Autor:
Thomas Kunzke, Fabian T. Hölzl, Verena M. Prade, Achim Buck, Katharina Huber, Annette Feuchtinger, Karolin Ebert, Gwen Zwingenberger, Robert Geffers, Stefanie M. Hauck, Ivonne Haffner, Birgit Luber, Florian Lordick, Axel Walch
Publikováno v:
Clinical and Translational Medicine, Vol 11, Iss 9, Pp n/a-n/a (2021)
Externí odkaz:
https://doaj.org/article/a209e45f32244846aabeedb91561d7bf
Autor:
Simone Keller, Gwen Zwingenberger, Karolin Ebert, Jan Hasenauer, Jacqueline Wasmuth, Dieter Maier, Ivonne Haffner, Katrin Schierle, Gregor Weirich, Birgit Luber
Publikováno v:
Molecular Oncology, Vol 12, Iss 4, Pp 441-462 (2018)
The molecular mechanism of action of the HER2‐targeted antibody trastuzumab is only partially understood, and the direct effects of trastuzumab on the gastric cancer signaling network are unknown. In this study, we compared the molecular effect of
Externí odkaz:
https://doaj.org/article/571ae92aa32e4ace9c65ebc568745dab
Autor:
Axel Walch, Na Sun, Florian Lordick, Rupert Langer, Drolaiz H.W. Liu, Birgit Luber, Ivonne Haffner, Annette Feuchtinger, Achim Buck, Jian Shen, Verena M. Prade, Thomas Kunzke, Jun Wang
Supplementary Data from Spatial Metabolomics Identifies Distinct Tumor-Specific Subtypes in Gastric Cancer Patients
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1d5e2ec9c5c9382ab6835d9afb21ac36
https://doi.org/10.1158/1078-0432.22487207
https://doi.org/10.1158/1078-0432.22487207
Autor:
Axel Walch, Na Sun, Florian Lordick, Rupert Langer, Drolaiz H.W. Liu, Birgit Luber, Ivonne Haffner, Annette Feuchtinger, Achim Buck, Jian Shen, Verena M. Prade, Thomas Kunzke, Jun Wang
Purpose:Current systems of gastric cancer molecular classification include genomic, molecular, and morphological features. Gastric cancer classification based on tissue metabolomics remains lacking. This study aimed to define metabolically distinct g
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9dc1bbcaa2feee0f0219e3d0ce1b89b0
https://doi.org/10.1158/1078-0432.c.6532466
https://doi.org/10.1158/1078-0432.c.6532466
Autor:
Katharina Kolbe, Ivonne Haffner, Katrin Schierle, Dieter Maier, Birgitta Geier, Birgit Luber, Hendrik Bläker, Christian Wittekind, Florian Lordick
Publikováno v:
Journal of cancer research and clinical oncology.
Purpose The prospective multicenter VARIANZ study aimed to identify resistance biomarkers for HER2-targeted treatment in advanced gastric and esophago-gastric junction cancer (GC, EGJC). HER2 test deviations were found in 90 (22.3%) of 404 cases (cen
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8f60176097d931d59fb6748dae9c0231
https://pubmed.ncbi.nlm.nih.gov/36030286
https://pubmed.ncbi.nlm.nih.gov/36030286
Autor:
Jun Wang, Na Sun, Thomas Kunzke, Jian Shen, Annette Feuchtinger, Qian Wang, Raphael Meixner, Ronan Le Gleut, Ivonne Haffner, Birgit Luber, Florian Lordick, Axel K. Walch
Publikováno v:
SSRN Electronic Journal.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::72d9226933556f11a91752c67e2cbbc0
https://doi.org/10.2139/ssrn.4176351
https://doi.org/10.2139/ssrn.4176351
Autor:
Jun Wang, Thomas Kunzke, Verena M. Prade, Jian Shen, Achim Buck, Annette Feuchtinger, Ivonne Haffner, Birgit Luber, Drolaiz H.W. Liu, Rupert Langer, Florian Lordick, Na Sun, Axel Walch
Publikováno v:
Clinical Cancer Research, 28(13), 2865-2877. American Association for Cancer Research Inc.
Clin. Cancer Res. 28, 2865-2877 (2022)
Clin. Cancer Res. 28, 2865-2877 (2022)
Purpose: Current systems of gastric cancer molecular classification include genomic, molecular, and morphological features. Gastric cancer classification based on tissue metabolomics remains lacking. This study aimed to define metabolically distinct
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d117eea93f39534f0cd0dfaabe42a6c6
https://pubmed.ncbi.nlm.nih.gov/35395077
https://pubmed.ncbi.nlm.nih.gov/35395077
Autor:
Miriam Ahlborn, Ivonne Haffner, Florian Lordick, Gabriele Margareta Siegler, Jan Hasenauer, Birgit Luber, Jorge Riera Knorrenschild, Ludwig Fischer von Weikersthal, Axel Walch, Dieter Maier, Elba Raimúndez, Christian Wittekind, Katrin Schierle, Thomas Decker, Beate Rau, Katharina Kolbe, Birgitta Geier, Stefan Fuxius, Albrecht Kretzschmar
Publikováno v:
J. Clin. Oncol. 39, 1468-1478 (2021)
PURPOSE Trastuzumab is the only approved targeted drug for first-line treatment of human epidermal growth factor receptor 2–positive (HER2+) metastatic gastric cancer (mGC). However, not all patients respond and most eventually progress. The multic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8425045b8a5d2f80e13039d47885ec25
https://push-zb.helmholtz-muenchen.de/frontdoor.php?source_opus=61686
https://push-zb.helmholtz-muenchen.de/frontdoor.php?source_opus=61686